About

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, founded in 1958. Specializing in artificial heart valves and hemodynamic monitoring, the company reported a revenue of US$ 5.44 billion in 2024. A key product in its portfolio is the Sapien transcatheter aortic heart valve, innovatively crafted from cow tissue within a balloon-expandable, cobalt-chromium frame, and deployed via catheter. As a public company, Edwards Lifesciences operates manufacturing facilities globally, including its Irvine headquarters, Draper, Utah, Costa Rica, the Dominican Republic, Puerto Rico, Singapore, and a new facility in Limerick, Ireland completed in 2021.